SBRASabra Health Care REIT, Inc.

$21.02

Price

$21.02+20%1Y
1M-4.6%1Y+20%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average
5/10
Value30
Quality62
Momentum42
Growth85
Strongest Growth, weakest Value · ranked vs Real Estate peers. The five questions below judge the company on its own terms.
What they do

We elected to be treated as a REIT with the filing of our U.S. federal income tax return for the taxable year beginning January 1, 2011. We believe that we have been organized and have operated, and we intend to continue to operate, in a manner to qualify as a REIT. We operate through an umbrella partnership, commonly referred to as an UPREIT structure, in which substantially all of our properties and assets are held by Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which we are the sole general partner and a wholly owned subsidiary of ours is currently the only limited partner, or by subsidiaries of the Operating Partnership.

In the company’s own words · 10-K filed Feb 12, 2026 · SEC EDGAR

P/E (TTM)33.4
Market Cap$4.57B
1Y Return+20%
5Y Return+68%

Sabra Health Care REIT, Inc. (SBRA) reported revenue of $222M in Q1 2026 (quarter ended March 31, 2026), up 21% from the same quarter a year earlier. That came with net income of $41M (18% of revenue). For the full year FY2025, revenue was $775M (+10% year on year) and net income $156M.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.